Skip to main content

Table 2 Model inputs

From: Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

ParametersBase case valueRange tested (%)
Unit drug costs (RMB)
 Unit cost of docetaxel (cost per mg)73.62± 20
 Unit cost of abiraterone (cost per mg)0.58± 20
 Unit cost of prednisolone/prednisone (cost per mg)1.33± 20
Dosage
 Daily dosage of docetaxel (mg/m2)75± 20
 Daily dosage of abiraterone (mg)1000± 20
 Daily dosage of prednisolone (mg)5± 20
 Average height (m)1.615± 20
 Average weight (kg)61.8± 20
Other medical costs (RMB)
 Hospitalisation costs for chemotherapy318± 20
 Preventive drugs for chemotherapy620± 20
 ADT cost per month2050± 20
 Laboratory test costs500± 20
 Inpatient OOP 15± 20
 Outpatient OOP %25%± 20
Costs of adverse events (RMB)
 Hypertension98.70± 50
 Hypokalaemia65.00± 50
 ALT increased225.68± 50
 Hyperglycaemia115.00± 50
 AST increased225.68± 50
 Bone pain583.00± 50
 Cardiac disorder1000.00± 50
 Anaemia271.70± 50
 Back pain73.60± 50
 Spinal-cord compression1235.00± 50
 Fatigue540.44± 50
 Allergic reaction75.00± 50
 Diarrhoea31.44± 50
 Stomatitis74.00± 50
 Neuropathy375.84± 50
 Thromboembolism1794.20± 50
 Sudden death3200.00± 50
 Thrombocytopenia3518.04± 50
 Neutropaenia720.80± 50
 Febrile neutropaenia1787.20± 50
 Infection with neutropaenia14,764.05± 50